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Sepsis, a life-threatening condition caused by infection, is a leading cause of mortality 
and morbidity globally. Researchers suggest that early identification of sepsis upon 
admission to the emergency department (ED) can help mitigate the consequences of 
sepsis. The emergency department of a hospital in a large urban U.S. city has participated 
in the Centers for Medicare & Medicaid Services’ sepsis reporting system (SEP-1) since 
2015; however, recent reports indicated below benchmark scores. As more than half of 
patients diagnosed with sepsis were admitted or readmitted through the ED, the purpose 
of this project was to develop a clinical practice guideline, informed by Rosswurm and 
Larrabee’s evidence-based practice model and a literature search, for use in the ED with 
input from an expert advisory panel using the AGREE II tool criteria across six domains. 
A 4-member panel member,  comprised of the ED’s medical director, director of nursing, 
nurse manager, and an ED staff nurse unanimously recommended the use of the 
guideline. Domain scores ranged from 40 to 100%, with a mean of 83%. This  sepsis 
clinical guideline scored highest in the domains of scope and purpose (100%) and clarity 
and presentation (95%) and applicability (83%). The domains of stakeholder involvement 
(40%) and editorial independence (57%) had the lowest domain scores. The overall 
quality assessment score was 7 based on a Likert scale ranging from 1 (lowest possible 
quality) to 7 (highest possible quality). In making sepsis screening a routine practice 
informed by a clinical guideline, nurses at the project site may be able to identify sepsis 
earlier in patients presenting to the ED, resulting in improved outcomes, promoting a 
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Section 1: Nature of the Project 
Introduction 
Sepsis is a life-threatening condition caused by infection and represents a 
substantial global health burden. As a leading cause of mortality and morbidity, sepsis is 
responsible for more than five million patients dying yearly around the world (Centers for 
Disease Control and Prevention [CDC], 2016). The CDC (2016) noted that one in every 
three patients in the United States who die in the hospital dies from sepsis with most 
patients presenting with symptoms of infection on arrival at the hospital. Among those 
patients who are discharged after being treated for sepsis, 40% are readmitted to the 
hospital within 3 months with more than 70% of those readmitted having physical and 
cognitive functional decline (Al Khalaf et al., 2015; Iwashyna et al., 2010).  
Early identification of sepsis and interventions are key elements in preventing this 
decline as well as preventing increased length of stay and mortality in this population. 
Both early identification and timely and appropriate interventions have been reported to 
decrease mortality and improve patient outcomes (Kim & Park, 2019). Nurses are in a 
unique position to identify the early signs of sepsis in patients presenting to the 
emergency department (ED) as they complete an initial assessment upon the patient’s 
entry to the ED. Equipped with a clinical guideline on early identification, nurses may be 
able to ensure timely recognition of patients showing signs of sepsis that will prompt 




This project was based on the premise that use of an early identification sepsis 
clinical guideline by nurses in an ED located in a large urban center can improve sepsis 
management, reduce its burden, and support adherence to the Sepsis National Hospital 
Inpatient Quality Measure [SEP-1] (Dellinger, et al., 2004) quality measure. The Centers 
for Medicare & Medicaid Services (CMS) developed SEP-1 to address the need for 
timely delivery of high-quality sepsis care in U.S. hospitals. Officials use the SEP-1 as a 
quality indicator to measure a hospital’s adherence to standards in comparison with other 
hospitals. Adherence to CMS quality measures is vital as hospitals risk losing 
accreditation with poor compliance.  
The Doctor of Nursing Practice (DNP) project site--the ED of a hospital in a large 
urban U.S. city--provided an opportunity for improvement in the early identification of 
sepsis in the adult patient population, as more than half of patients diagnosed with sepsis 
are admitted or readmitted through the ED. Although the project site has participated in 
the SEP-1 reporting system since 2015, recent reports indicate scores that are below 
benchmark. In making sepsis screening a routine practice informed by a clinical 
guideline, ED nurses may be able to maximize outcomes for this population and 
increase the SEP-1 scores. 
Purpose 
The purpose of this project was to develop a clinical practice guideline (CPG) 
with input from an expert panel. The practice-focused question was: Can a 
multidisciplinary group develop evidence-based CPGs that meet the AGREE II criteria 
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for the screening and early identification of sepsis in patients presenting to the ED? 
Screening can lead to expedited delivery of care to patients with sepsis. Sepsis 
guidelines dictate that patients should receive antibiotics within 3 hours of admission to 
the institution making early identification crucial to quality outcomes. However, the 
patient must first be identified as having sepsis (Klienpell & Schorr, 2016).  
Nature of the Doctoral Project 
The purpose of this project was to develop a CPG with input from an expert 
panel. I developed a CPG on screening and early identification of patients for sepsis who 
present to an urban ED. The purpose of a CPG is to narrow the gap between an 
organization's current practice and delivery of optimal care (Graham et al., 2011; Holly, 
et al. 2021). The gap that exists is lack of early identification of sepsis in the adult 
population presenting to the project ED resulting in the SEP-1 reports as below 
benchmark. By following a guideline for early screening and early identification, nursing 
staff may be able to diagnose and treat sepsis in a timelier manner. 
Sources of evidence used in this project included a literature review to support 
developing a clinical guideline on the early identification of sepsis in the ED using 
Medline/PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
and the Cochrane Library. I constructed a table of evidence. The latest recommendations 
from the Surviving Sepsis Campaign were integrated into the guideline. Following 
completion of the guideline, an expert panel assessed the guideline using the AGREE II 




Sepsis is the 11th leading cause of death in the United States and the 10th for 
those 65 years of age or older (Hayden et al, 2016; Rhodes et al., 2016). Between 2008 
and 2011, combined Medicare and Medicaid inpatient reimbursements for sepsis totaled 
$17.7 billion, 5% of which was for hospital stays classified as high-cost outliers (Torio & 
Andrews, 2013). Reported in-hospital death rates vary by severity, ranging from 11% for 
sepsis to more than 40% for septic shock (Gajeski et al., 2013). Early identification in the 
ED to support focused interventions is essential for treating most life-threatening 
diseases, including myocardial infarction, stroke, and cardiac arrest (Kleinpell, 2017). 
However, compared with identification of these conditions, early identification of sepsis 
is more complex as early signs are more subtle. The Surviving Sepsis Campaign 
recommends the use of sepsis screening, which has been shown to reduce treatment time 
and improve outcomes (Rhodes et al., 2016). Screening, for the purposes of this project, 
was supported by the development of a sepsis clinical guideline for early identification of 
sepsis in adult patients admitted to the ED. Stakeholders in this project were patients who 
presented to the project site’s ED, ED nurses, and ED leadership. Moran et al. (2017) 
stated that support and participation by stakeholders will increase stakeholders' awareness 
and commitment to the process thus increasing the project’s credibility. Improvement in 
the hospital SEP-1 benchmark will denote excellence in the care of the sepsis patient, 
demonstrate that the organization is committed to maintaining a high standard of clinical 
care, potentially provide the project site with a competitive edge in reimbursement, and, 




Sepsis is a severe health condition associated with a high mortality rate. Positive 
patient outcomes are associated with the early identification and treatment of this 
condition (Baison et al., 2019). More than a third of patients presenting with sepsis 
symptoms are admitted through the project site ED making the area vital in lowering 
patient mortality. Early goal-directed therapy (EGDT) for sepsis is dependent on the 
timely recognition of the patient with sepsis. Nurses, as the largest bedside healthcare 
provider, play a key role in ongoing monitoring of a patient’s condition. As such, nurses 




Section 2: Background and Context 
Introduction 
The purpose of this project is to develop a CPG with input from an expert panel to 
address the practice problem of lack of early identification of patients presenting to an 
urban ED with signs suspicious of sepsis. The question I sought to answer in the project 
was: Can a multidisciplinary group develop evidence-based CPGs that meet the AGREE 
II criteria for the screening and early identification of sepsis in patients presenting to the 
ED? 
Sepsis is a clinical syndrome that triggers physiologic, biologic, and biochemical 
abnormalities. It is a multifaceted response to infection and results in organ dysfunction, 
which is attributed to insufficient tissue perfusion and oxygen delivery (Keep,2015). 
Sepsis often begins when there is an infection in the body, whether bacterial, viral, 
fungal, or parasitic. Potential sources of infection include the lungs, abdomen, urinary 
tract, skin, intestines, brain, and bone, which are the most common venues for sepsis 
((Keep,2015)).   
Sepsis symptoms include shaking, chills, fever, weakness, rapid heart rate, rapid 
breathing, low blood pressure, decreased urine output, nausea, vomiting, and diarrhea. 
(Keep, 2015).  The earliest indication of sepsis is the presence of temperature, less than 
36°C (96.8 F) or greater than 38.3°C (100.9 F) (Keep,2015). Other commonly seen vital 
signs associated with sepsis include a heart rate greater than 90 beats per minute and/or 
respiratory rate greater than 20 breaths per minute (Keep,2015). Any of these signs 
should prompt the triage nurse to suspect sepsis, thus triggering an emergency response 
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(Keep et al, 2015). However, the hallmark of diagnosing sepsis is obtaining a blood 
culture to identify the causative organism, so that the proper antibiotic is provided.    
Sepsis is a life-threatening condition that if not treated early in its onset has a high 
mortality rate and poor patient outcome (Keeley et al., 2017, Levy et al, 2020; Thompson 
et al., 2019). Patients presenting to hospital with diagnosis of sepsis require prompt and 
aggressive management to prevent complications and to improve outcomes as sepsis is a 
leading cause of morbidity and mortality (Baison et al., 2019). The World Health 
Organization (2019) identified sepsis as a global health crisis affecting more than 49 
million individuals and resulting in more than 11 million deaths yearly.  
Clinical Practice Guidelines 
CPGs are statements that are systematically developed from a critical analysis of 
the literature about a clinical question to assist practitioners in making appropriate 
decisions regarding providing health care for specific clinical situations or conditions 
(Graham et al., 2011). Guidelines promote high-quality, evidence-based health care and 
decrease or reduce inappropriate variations in practice. The goal of a CPG is to optimize 
patient care and improve patient outcomes (Emergency Nurses Association, 2015, The 
National Academies of Science Engineering and Medicine: Health and Medicine 
Division, 2018).).  
The purpose of CPGs is to narrow the gap between an organization's current 
practice and optimal care. CPGs guidelines can be a reference for clinicians, providing 
information and supporting materials such as methodology, scientific evidence, and a 
comprehensive bibliography (Holly et al., 2021). Guidelines focus on specific clinical 
8 
 
circumstances, which may sometimes include clinically relevant organizational factors, 
community characteristics, social variables, and similar influences on health care 
delivery. 
CPGs have a range of purposes and are intended to improve effectiveness and 
quality of care, decrease clinical practice variations, and decrease costly and preventable 
mistakes and adverse events  (Agbassi, 2014). They usually include expected practice 
statements; provide benchmarks or standards against which individuals can audit, 
compare, and potentially improve their practices; or offer guidance regarding undertaking 
tasks (Agbassi, 2014). The clarity of the guidelines determines a CPG’s effectiveness and 
whether it is appropriate for the individual condition (Agbassi, 2014). CPGs can improve 
processes and patient outcomes; however, their effectiveness is determined by the 
organizational structures that support or undermine evidence-based practice and 
successful implementation. CPGs must be well developed, be based on current scientific 
evidence, and be user-friendly to be readily adopted (Busse et al., 2019). CPGs require 
periodic revision and reviewing to guarantee that the recommended guidelines are current 
and valid (Agbassi, 2014).  
In 2004, the Surviving Sepsis Campaign recommended early goal-directed 
therapy (EGDT) to manage severe sepsis and septic shock to decrease sepsis mortality by 
25% over the following 5 years globally. Campaign officials developed the international 
guidelines in response to the deadly effects of sepsis and to find means to improve the 
morbidity and mortality rate (Dellinger et al., 2012). The Surviving Sepsis Campaign 
guidelines were developed in 2004 and revised in 2008, 2012, and 2015. The aims of the 
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guidelines for sepsis diagnosis and management were to reduce the mortality rate, 
improve patients’ outcomes, and ensure a more reliable and timely application of 
evidence-based care and standardized clinical practice with evidence-based bundles 
(Dellinger et al., 2015). A bundle is a set of interventions that, when implemented 
together, result in better outcomes than when implemented separately. The recommended 
3-hour bundle requires that a blood culture be obtained before administration of any 
antibiotic, that blood for lactate levels be sent to the laboratory for analysis, that broad 
spectrum antibiotics be administered, and that 30 mL/kg of crystalloid fluid for 
hypotension mean arterial pressure (MAP) < 65 or lactate > 4 be administered as 
necessary (Dellinger et al. 2017). 
The upgraded 2017 bundle recommendation is treatment within the first hour 
known as time zero or time of presentation at triage in the ED or at the earliest time of 
known assessment for sepsis symptoms in other clinical areas (Dellinger et al., 2017). 
Clinicians can adapt and use the evidence-based guidelines recommended by the 
Surviving Sepsis Campaign to impact patient outcomes and improve patient mortality 
rates. Many researchers have adapted the Surviving Sepsis Campaign guidelines using 
different strategies to change practices and improve sepsis outcomes in emergency and 
inpatient units. 
Romero et al. (2017) sought to establish the impact of implementing the sepsis 
guidelines on triage assessment, ED management, and time to antibiotics. The 
investigators conducted the study in a metropolitan Australian tertiary referral ED serving 
a population of 70,000 annually. The Australian New South Wales government had 
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identified that the recognition, assessment, and management of sepsis was a significant 
challenge for ED clinicians. The recommendation was the standardization of sepsis 
management of patients presenting with sepsis by emergency clinicians and triage nurses. 
The sample included 157 patients pre- and postintervention. The intervention strategy 
included an educational component for ED clinicians. The investigators selected a 
randomized sample of medical records of presepsis guidelines over 12 months and the 
same for postintervention patients (12 months). They audited records by comparing the 
pre- and posteffect and identified that the sepsis guideline created a significant change in 
the clinicians' management of sepsis patients. The time to antibiotics was within 60 
minutes and significantly improved in the post sepsis guideline group. The time for the 
pre- and post-group for patients to be seen by a nurse or doctor after triage was 39 
minutes before guideline implementation. This decreased to 20 minutes after 
implementation. There was also a 758 minute (12.6 hours) mean reduction in time to the 
second liter of intravenous fluids (IVF) when comparing the pre- and post-group. 
As well, Oliver (2018) conducted a retrospective chart review in a rural hospital 
in Arkansas in a 33-bed ED treating over 70,000 patients yearly. Oliver measured if 
implementing a sepsis assessment tool can increase the early recognition of a sepsis 
patient and increase blood culture collection before antibiotic administration, and 
decrease door to diagnosis times, presentation time to serum lactate measurement, and 
diagnosis to antibiotic times. The investigator concluded that a screening tool could 
improve the quality of care for sepsis patients and suggested that the assessment tool be 
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embedded in the electronic medical record triage process as it would benefit the nurses 
and promote compliance. 
 Gyang and colleagues (2015) conducted a pilot study to determine if using a 
screening tool for sepsis as part of the nursing assessment may identify early sepsis in an 
inpatient unit. Nurses involved in the pilot study had extensive education on sepsis and 
related information before the pilot study. Clinical data were retrospectively analyzed 
over 1 month. The medical team evaluated those patients who screened positive for sepsis 
or severe sepsis and recorded their interventions. They screened 245 patients (169 
surgical patients, 76 medical patients). Thirty-nine patients screened positive; 51% were 
positive for sepsis, and 49% screened positive for severe sepsis. The screening tool 
sensitivity and specificity were 95% and 92%, respectively. The test accuracy was 92%. 
No statistically significant difference was noted.  
Rusconi et al. (2015). conducted a systematic review and meta-analysis to assess 
the effectiveness of EGDT versus usual care in the treatment of septic shock in those 18 
years of age or older with a sepsis diagnosis. Rusconi et al. based their study on River et 
al.'s (2006) landmark review stating that EGDT can reduce mortality with severe sepsis 
and septic shock. Clinical studies were identified by searching the MEDLINE, EMBASE 
databases and the Cochrane Central Register of Controlled Clinical Trials. The purpose 
was to identify randomized controlled trials assessing the effectiveness of EGDT for 
sepsis. The data from five studies, enrolling 4,033 patients, were included in the meta-
analysis and analyzed using a random-effects model. The electronic search yielded 3,551 
citations: 1,115 references in MEDLINE and 2,436 in EMBASE. Six hundred forty-nine 
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references were duplicated between the two databases. Of a total of 2,902 references, 
only 17 were relevant to the title and abstract screening. Due to variability across the 
studies, the reviewers did not have a definitive conclusion about the effectiveness of 
EGDT on severe sepsis and septic shock. Although Rosconi et al did not agree about the 
EGDT effectiveness, Jirajariyave et al (2018) stated that sepsis is a serious disease with 
high mortality and implied that early hemodynamic resuscitation after diagnosis with 
severe sepsis or septic shock can led to lower organ dysfunction together with lower in-
hospital mortality rates.  
Rhodes et al. (2017 evaluated the recommendations using the Surviving Sepsis 
Campaign guidelines. The researchers formed a consensus committee of 55 international 
experts from 25 international organizations grouped to evaluate Surviving Sepsis 
Campaign Guidelines for sepsis. The consensus committee was then further divided into 
subgroups. The committee used the principles of the Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) methodology in assessing the 
quality of evidence from high to low and to formulate recommendations as strong or 
weak or best practice statements (related to hemodynamics, infection, adjunctive 
therapies, metabolic, and ventilation). The Surviving Sepsis Guideline panel evaluated 93 
reports on early management and resuscitation of sepsis or septic shock patients. Of the 
results, 32 were strong recommendations, 39 were weak recommendations, and 18 were 
best-practice statements. 
In conclusion, even though early sepsis intervention is critically important to 
patient survival, compliance in the clinical setting remains low. In institutions, the 
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primary issue is identifying sepsis early in a patient, making early recognition one of the 
most crucial aspects in sepsis care. Furthermore, clinicians need to know the importance 
of time for sepsis patients and understand their roles in the patient's outcome. All 
clinicians must understand the urgency and importance of time associated with sepsis 
management.The Surviving Sepsis Campaign's guidelines can provide on-hand resources 
to clinicians to help identify and manage sepsis treatment promptly. However, many 
institutions do not have a detailed clinical guideline based on the campaign’s 
recommendations to assist nursing clinicians in using real-time resources. Evidence-
based clinical guidelines are tools that guide a clinician’s practice (Holly et all, 2021). 
CPGs have the potential to reduce practice variations and improve the translation of 
research into practice. A guideline based on scientific evidence can improve patient 
outcomes by optimizing the process of care. A clinical guideline for the project institution 
may help nursing clinicians in their decision-making to reduce delays from first medical 
contact to appropriate therapy and avoid systemic errors when facing a suspected sepsis 
case. 
Concepts, Models, and Theories 
I used Rosswurm and Larrabee’s (1999) evidence-based practice model as the 
foundation for this project. The model describes a process for guiding nurses to integrate 
evidence into their practices. The model has six stages: (a) assess the need for a practice 
change; (b) link the problem, interventions, and outcomes; (c) synthesize best evidence; 
(d) design the practice change; (e) implement/evaluate the change; and (f) 
integrate/maintain the change. 
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Step 1. Assess the Need for Change in Practice: Major steps in this phase are 
identification of stakeholders, collection of internal data about current 
practice, comparison of internal and external data to confirm the need for a 
practice change, identification of the practice problem, and linking the 
problem interventions and outcomes (Larrabee, 2009). The DNP project site 
demonstrated an opportunity for improvement in the early identification of 
sepsis in the adult population presenting to the ED as more than half of 
patients diagnosed with sepsis are admitted or readmitted through the ED. 
Although the project site has participated in the SEP-1 reporting system since 
2015, recent reports indicate below benchmark scores (Larrabee, 2009). 
Step 2. Locate the Best Evidence: Major steps in this phase are identifying the 
best available evidence upon which to build the CPG. For this project, I 
developed keywords and inclusion and exclusion criteria to guide a search 
using Medline/PubMed, CINAHL, and the Cochrane Database of Systematic 
Reviews available in the Walden University Library (Larrabee, 2009). 
Step 3. Critically Analyze the Evidence: Major steps in this phase are critically 
appraising and weighing the strength of the evidence; synthesizing the best 
evidence; and assessing the feasibility, benefits, and risks of the new practice. 
I determined levels of evidence and GRADE recommendations during this 
step (Larrabee, 2009). 
Step 4. Design Practice Change: Major steps in this phase are defining the 
proposed practice change and identifying the needed resources. In this phase, I 
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used the relevant articles found in searching the library and recommendations 
of the Surviving Sepsis Campaign to develop the CPG for early sepsis 
identification (Larrabee, 2009). 
Although this project did not include implementation, this model can continue 
to be used by stakeholders in the future for implementation purposes 
following the development of the guideline.  
Step 5. Implement and Evaluate Change in Practice: Major steps in this phase are 
implementing a pilot study; evaluating the processes, outcome, and costs; and 
developing conclusions and recommendations (Larrabee, 2009). 
Step 6. Integrate and Maintain Change in Practice: Major steps in this phase are 
communicating recommended change to stakeholders, integrating the new 
practice into standards of practice, monitoring the process and outcomes 
indicators, and celebrating and disseminating the results of the project 
(Larrabee, 2009).  
Relevance to Nursing Practice 
Nurses are the largest provider of care in the ED and usually the first contact for 
patients arriving in the department, usually at the triage process, making their role crucial 
in the early recognition of sepsis symptoms. The patient sepsis outcome depends on early 
recognition as delayed management can create a negative outcome. The key to early 
identification is the nurse who first encounters the patient and suspects sepsis and 
initiates an alert to the clinical team. Registered nurses are responsible for assessing 
patients using the nursing process. As the role of the assessor of a patient, the registered 
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nurse is vital to the outcome of patients diagnosed with sepsis. Seventy percent of 
patients are admitted through the ED making it the most appropriate area for using 
guidelines for early recognition and management of septic patients (Al Khalaf et al., 
2015; Iwashyna et al., 2010).  
The American Nurses Association (2015) supports nursing interventions utilizing 
evidence from research studies to improve patient outcomes. Evidence-based practice is 
the process of gathering, processing, and incorporating research findings to improve 
clinical practice, the work environment, or patient outcomes.  The utilization of evidence-
based practice in nursing practice supports the provision of the highest quality of patient 
care thus the evidence-based sepsis guidelines should be applied to patients presenting to 
an institution with suspected sepsis symptoms. Sepsis can be difficult to identify as other 
conditions present with the same signs and symptoms; nurses must be aware of the 
Surviving Sepsis Campaign evidence-based guidelines strategies to identify and manage 
sepsis. Providing resources that alert practicing clinicians to diagnosis can aid in making 
informed decisions to identify sepsis.  Sepsis is a time-dependent emergency that requires 
prompt, effective interventions that focused on reducing the interval between a suspected 
sepsis diagnosis and the effective evidence-based practice management that can improve 
the patient outcome.  
 Early recognition of sepsis can be a challenge.  Where barriers to improving 
sepsis care exist, nursing education that teaches adherence to a policy or guideline has the 
potential of impacting sepsis outcome. Identifying and addressing barriers to sepsis 
recognition is vital in optimizing patients’ outcomes.  Implementation of a CPG can 
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provide the needed resources and empower clinical nurses to impact patient outcomes.  
Advanced practice nurses such as DNP students/scholars can actively contribute and lead 
positive patient outcomes by using evidence based, sustainable, context-sensitive 
solutions. through ongoing evaluation and research in expanding body of knowledge as 
well as actively participating in health policy agenda in all levels (Bateson & Patton, 
2015). 
Local Background and Context 
The setting for this doctoral project was a 530-bed not-for-profit urban teaching 
hospital in a large Northeastern U.S. city that provides a wide range of services including 
medical-surgical, thoracic, cardiac, neurological, and pediatric services. It is a Level 2 
Trauma Center with an ED with more than 100,000 visits yearly. The project site is 
designated as a critical access hospital, where individuals who are acutely ill are seen in 
large numbers due to the closure of many nearby healthcare facilities.  
To improve quality care and reimbursement, the hospital began to participate in 
the CMS core-bundle SEP-1 in October 2015. However, the hospital sepsis care had 
fallen below the benchmark each year since participating in SEP-1.  In the last few years 
according to state report on Hospital Quality Performance on Sepsis Care Improvement 
Initiative, the project institution was reported in the category of lowest performer in the 
3- hour bundle and worst performer in the 6-hour bundle, such that the project institution 
was below the 50th percentile in the 3-hour bundle and below the 20th percentile in the 6-
hour bundle (see Appendix A). The performance on these sepsis measures makes the 
project institution an ideal place for utilizing a CPG. The ED admits approximately 70% 
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of patients diagnosed with sepsis, making it the most appropriate area for a sepsis 
guideline to be initiated.  
Role of the DNP Student 
The DNP Essentials refers to the student's education by outlining the curriculum 
and competencies needed before conferring a DNP degree. Eight skills are the initial 
outcome competencies deemed essential for all graduates of a DNP regardless of 
specialty. The DNP graduate is prepared to use the knowledge gained from ethics, 
biophysical, psychosocial analytical, and organizational sciences, incorporating it into 
nursing science to provide the optimal nursing practice. The graduate used advanced 
strategies to enhance, alleviate, and improve health and health care delivery using 
scientific theories to develop and evaluate new practice approaches. The Doctor of Nurse 
Practice Essential II: Organizational and Systems Leadership for Quality Improvement 
states that the graduate role should contribute to nursing science by evaluating, 
translating, and research into practice (American Association of Colleges of Nursing 
(2006). 
The DNP student's role in the project is to review and analyze evidence-based 
research to develop and inform the CPG development and to lead the project team in the 
assessment of the sepsis guideline using the AGREE II tool. As a DNP student, using the 
knowledge I gained from Walden University and the experience as an ED nurse to assess, 
I analyzed gaps in nursing practices, analyzed and reviewed evidence-based research, 
translated it into nursing practices in the form of an CPG with the intent to improve 
processes and patient outcomes for those patients presenting to the ED with sepsis. 
19 
 
Role of the Project Team 
The project team was a multidisciplinary group from the ED at the project site. 
The team consisted of the ED medical director, ED nursing director of the nursing, ED 
nurse manager, and ED staff nurse. The chairman and nursing director facilitated the 
DNP student's access to the sepsis information and mentored the student throughout the 
project. The project team reviewed the clinical guidelines and assessed it using the 
AGREE II tool to aid in the eventual recommendation of the guideline. 
Summary 
In this section, I described the uses and current research on the use of clinical 
guidelines for early sepsis identification. Rosswurm and Larrabee’s (1999) model guided the 
project as it is a change theory that guides a systematic approach to developing and 
integrating an evidence-based practice change. Four stages of the model were used. Stages 
five and six can be used to implement, disseminate, and maintain the guideline, but were not 
used in this project. Using this model assisted in the use of a  systematic process develop a 
CPG 
The ED is the most used port of entry for sepsis patients, making it an ideal area to 
start a sepsis management CPG. Providing a resource guideline is ideal and necessary for 
nurses as the largest provider of care. They are usually the first contact with patients arriving 
in the department, typically at the triage stage, making their role crucial in the early 
recognition of sepsis symptoms. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
CPGs support the uptake of evidence into practice.  They are developed to 
provide healthcare practitioners with up-to-date information to make evidence-informed 
decisions about health care and interventions for specific clinical conditions at the point 
of care (Holly, et al. 2020). In this project, I developed a CPG using the Walden 
University Manual on Development of Clinical Guidelines and the following four steps in 
guideline development based on Rosswurm and Larrabee’s (1999) evidence-based 
practice model: 
1. Identifying and refining the target area 
2. Assessing evidence identified by systematic literature review. 
3. Translating evidence into recommendations. 
4. Subjecting the guideline to stakeholder review. 
Practice-Focused Question 
The guiding question for this project was: Can a multidisciplinary group develop 
evidence-based CPGs that meet the AGREE II criteria for the screening and early 
identification of sepsis in patients presenting to the ED? This guideline and its subsequent 
use may improve adherence to the SEP-1 quality measures and improve the early 
identification and management of sepsis in the ED.  
Sources of Evidence 
I reviewed the literature to identify evidence to support developing a clinical 
guideline on the early identification of sepsis in the ED. Sources for this search included 
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Medline/PubMed, CINAHL, and the Cochrane Library. The search parameters were from 
2004 to the present as 2004 was the initial publication of the Surviving Sepsis Campaign 
recommendations. Keywords and phrases used were sepsis, sepsis guidelines, early 
identification, screening, and sepsis outcomes. The guideline is evidence based in that the 
latest recommendations from the Surviving Sepsis Campaign and literature review were 
integrated. The use of guidelines increases adherence, according to researchers; Camp et 
al. (2014) noted, for instance, that using a clinical guideline to confirm understanding of 
discharge instructions, home care plans, and follow-up care promoted compliance to 
home regimens. 
Analysis and Synthesis 
Synthesis 
Appendix B presents the articles and other evidence I used in developing the 
guideline for the project. Synthesizing the articles involved concisely summarizing and 
linking different sources in a literature review on the topic and connecting the findings to 
the guideline elements to be evidence-based. Instead of describing each article 
individually, the integration of each source's main points resulted in overall evidence-
based conclusions. This involved looking for similarities and differences among evidence 
sources (Holly et al., 2020). I determined the level of evidence for each source using the 
Agency for Healthcare Research and Quality (AHRQ) guidelines for determining levels 
of evidence. The levels of evidence and GRADE recommendation of each source were 
assigned based on the quality of their design, validity, and applicability to patient care 
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(see Hendrickson et al. 2005). Using evidence levels enabled the expert panel to 
determine how much confidence to put into findings. 
Analysis 
After developing the guideline, I gave it to an expert panel that included the ED 
leadership (the director of nursing, director of medicine, nurse manager, and an ED staff 
nurse) who assessed, evaluated, and determined their agreement using the 23-item 
AGREE II instrument developed by Brouwers of McMaster University. This tool offers 
a consistent and effective way to evaluate clinical guidelines (AGREE Research Trust, 
2018). The instrument's two primary focus areas are overall guideline quality and 
recommendation for use. Hoffmann-Eber et al. (2018) investigated the AGREE II 
instrument's strength via a survey and found a robust assessment of guideline quality 
and recommended it for use. Although the AGREE II instrument can be time-consuming 
in comparison to other tools available, it is superior and the gold standard for clinical 
guideline appraisal because of its focus on quality and application of a guideline 
(Hoffmann-Eber et al. (2018). 
This was a minimal risk, non-human subject project, and no patient information 
was required for its completion. I obtained approvals to conduct the project from 
Walden University’s Institutional Review Board and the project site.  
Summary 
Sepsis is a condition associated with a high mortality rate and poor patient 
outcomes. Research has shown that EGDR for sepsis can positively impact patient 
outcomes if there is timely recognition and management of the patient with sepsis. 
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Multiple studies have confirmed that recognition and prompt treatment of sepsis, EGDT, 
and the use of protocols improve patient outcomes (Chen et al. 2020; Chiweshe & 
Ekelund, 2018; Ferguson et al. 2019; Hayden et al., 2016; Kleinpell,2017; Mattison et al., 
2016). Guidelines that integrate evidence-based research findings and meet the AGREE 
II criteria for the screening and early identification of sepsis in patients presenting to the 
ED may help alleviate sepsis patients' morbidity and mortality by providing on-time 




Section 4: Findings and Recommendations 
Introduction 
This DNP project was concerned with sepsis, a medical emergency in which 
outcomes depend on early recognition and rapid institution of resuscitative measures. 
Sepsis triggers physiologic, biologic, and biochemical abnormalities that are a 
multifaceted response to infection and results in organ dysfunction attributed to 
insufficient tissue perfusion and oxygen delivery. The local problem was a lack of early 
identification and treatment for patients presenting to an urban ED with signs of sepsis 
resulting in poor performance on the SEP-1 standards for sepsis. The gap in practice was 
lack of an evidence-based guideline to assist in early recognition. The purpose of this 
project was to develop that guideline following the Walden DNP Manual for Clinical 
Practice Guidelines. I conducted a literature search using PubMed, the CINAHL, 
Nursing & Allied Health Database (ProQuest), and the Cochrane Library. Search terms 
included in various combinations were sepsis, sepsis management in the ED, sepsis 
research, sepsis protocols, and sepsis guidelines. Studies were selected using the 
following criteria: original research, peer-reviewed, published in English, and with 5-year 
timeframe for date of publication. Each article was reviewed to determine relevance to 
the clinical question. I found 12 full-text articles that met the inclusion criteria and 
informed the development of the CPG and placed these in a table of evidence (see 
Appendix B). An expert panel reviewed the guideline against the AGREE II Tool to 
appraise the quality of the developed guideline. 
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Findings and Implications 
I found 12 articles that supported the development of the guideline. The articles 
were all peer reviewed and published between 2014 and 2019. Of these, one was Level I 
evidence (Rusconi et al., 2015); three were Level III evidence (Gyang et al., 2015; 
Romero et al., 2017; Trosvik et al., 2016); six were Level IV evidence (Freund et al., 
2017; Hayden et al., 2016; Leisman et al., 2019; Mattison, et al., 2016; Oliver, 2018; 
Potocka et al., 2014), and two were Level V evidence (Nishida et al., 2018; Rhodes et al., 
2017). As presented in Appendix B: 
• eight of the studies were conducted in the United States 
• one study each was conducted in Norway, Japan, England, and Australia 
• seven studies took place in an ED 
• one study took place on an oncology unit 
• one study took place in an intermediate care unit 
• two studies were consensus statements 
• one study was a systematic review 
The included studies were limited primarily using a single site in one hospital and 
the use of data from medical record reviews. As I discuss, I categorized each of the 
included studies by their level of evidence. Each study’s evidence was graded using the 





AHRQ Levels of Evidence 
Level of evidence     Description 
Level I      Meta-analysis of multiple studies 
Level II     Experimental studies 
Level III     Well-designed quasi-experimental studies 
Level IV     Well-designed non-experimental studies 




AHRQ GRADE Recommendation 
GRADE Recommendation 
 
A Strongly, recommend. Good evidence 
 
B Recommend. At least fair evidence 
 
C No recommendation for or against 
Balance of benefits and harms too close to 
justify a recommendation 
 
D Recommend against; Fair evidence is 
ineffective, or harm outweighs the benefit 
 
E Evidence is insufficient to recommend for 
or against routinely; Evidence is lacking 
or of poor quality; Benefits and harms 





Level I Evidence 
 Level I evidence is signified by a systematic review and meta-analysis according 
to the AHRQ Levels of Evidence (see Table 1). One study met this criterion (Rusconi et 
al., 2015). The researchers conducted a systematic review and meta-analysis to compare 
the effectiveness of EGDT to usual care in patients 18 years of age or older with 
suspected sepsis diagnosis. MEDLINE and EMBASE databases and the Cochrane 
Central Register of Controlled Clinical Trials were searched for studies that met their 
inclusion criteria. The authors concluded that most of the reviewed studies showed 
EGDT to be effective in the treatment of sepsis and recommended using EGDT until 
further evidence is available. According to the AHRQ Grade schema (see Table 2), the 
use of EGDT in the treatment of severe sepsis and septic shock would be considered 
GRADE A (Strongly recommend; Good evidence). Consequently, it is reasonable to 
consider EGDT in the care of patients with severe sepsis and septic shock. 
Level II Evidence 
There was no Level II evidence 
Level III Evidence 
Level III evidence is signified by a well-designed quasi-experimental study 
according to the AHRQ Levels of Evidence (see Table 1). Three studies met this 
criterion. Torsvik et al. (2016) conducted a non-randomized pre-post intervention study 
to investigate whether implementing a clinical tool for triage of systematic inflammatory 
response syndrome (SIRS), which included an organ failure alert prompt, treatment flow 
chart along with reinforced training to improve clinical observations. After analyzing 900 
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patients, Torsvik et al. realized that an increase in 30-day survival, less deterioration of 
sepsis patients to severe sepsis, and shorter length of stay in the ICU in the 
postintervention group could occur with the use of the clinical tool. According to the 
AHRQ GRADE recommendations (see Table 2), this would be GRADE A evidence 
(Strongly recommend; Good evidence). 
Romero et al. (2017) sought to establish the effect of sepsis guidelines on triage 
assessment, ED management, and time to antibiotics pre-and postimplementation of a 
sepsis guideline in a metropolitan institution ED serving 70,000 annually in New South 
Wales Australia. A new sepsis guideline was introduced into the ED to improve sepsis 
recognition, assessment, and management. Data were collected included patient 
demographics, clinical information (time of arrival, triage code, seen by time, disposition, 
time to antibiotic, pathology, time to intravenous fluids), and patient assessment data 
(heart rate, respiratory rate, blood pressure, temperature, oxygen saturation, medication). 
Romero et al. concluded that the sepsis guidelines improved the early assessment, 
recognition, and management of patients presenting with sepsis in the ED. The study 
established a statistically significant 230-minute reduction in time to antibiotics 
postimplementation of the guidelines. This study is GRADE A evidence (Strongly 
recommend, good evidence) 
Gyang and colleagues (2015) conducted an analysis to determine if using a 
screening tool as part of the nursing assessment could identify early sepsis on an inpatient 
unit. The assessments were conducted every 8 hours by nursing staff. A total of 2,143 
screening tests were completed for 245 patients (169 surgical, 76 medical). ICD-9 codes 
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confirmed that the sepsis incidence was 9%. Of the 39 patients who screened positive, 
51% were positive for sepsis, and 49% screened positive for severe sepsis. The primary 
team evaluated and provided intervention for patients screened positive for sepsis or 
severe sepsis and recorded management of interventions. The authors determined that a 
screening tool as part of a nursing assessment can identify early sepsis in medical and 
surgical patients. This is a GRADE B study (Recommend, at least fair evidence).  
Level IV Evidence 
Six of the included studies were Level IV evidence (Freund et al., 2017; Hayden 
et al., 2016; Leisman et al., 2019; Mattison et al., 2016; Oliver, 2018; Potocka, et al., 
2014) meaning that the evidence was generated from well-designed nonexperimental 
study. Patocka et al. (2015) utilized a triage screening tool in a retrospective chart review 
to detect septic patients presenting to the ED and determine the effect on time to 
antibiotics in patients with suspected severe sepsis or septic shock. The reviewers 
examined the time interval to antibiotics pre-and post-implementation of the triage tool. 
Patocka et al. concluded that a screening tool could decrease antibiotics in patients 
suspected of sepsis or septic shock. This study has Grade B evidence (Recommend; At 
least fair evidence). 
Mattison et al. (2016) investigated the use of a nurse-led protocol on time to 
antibiotic administration in patients with neutropenia in an oncology department in 
Northwest England. A chart review was performed 1 year after nurses were responsible 
for assessing patients presenting with fever post-chemotherapy, including prescribing and 
administering the first dose of intravenous antibiotics. The investigators concluded that 
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there was a significant improvement in the time to antibiotic postintervention and 
recommended that nurse-led protocols are safe and effective. This study is GRADE B 
(Recommend, at least fair evidence). 
Hayden et al. (2016) conducted a retrospective chart review to evaluate the 
effectiveness of early, rapid identification of sepsis during ED triage. The investigators 
hypothesized that a sepsis workup and treatment (SWAT) protocol that included rapid 
mobilization of resources, standardized order sets, and early broad-spectrum antibiotics 
and fluid resuscitation can reduce the time-to-intravenous fluids and time-to-antibiotics. 
The investigators collected pre-and postinterventional patient medical records to 
determine if a triage alert system and sepsis protocol can reduce door-to-antibiotics time, 
door-to-intravenous (IVF) bolus time, and overall mortality. The researchers found a 
reduction in the time-to-intravenous fluids and time-to-antibiotics in patients with 
suspected sepsis, severe sepsis, or septic shock after implementing an EHR-based triage 
sepsis alert using the SWAT protocol. This is GRADE B evidence (Recommend, at least 
fair evidence). 
Freund et al. (2017) conducted an international prospective cohort study using a 
retrospective data base with 879 patients with suspected infection treated in an ED. Freud 
et al. used screening tools, a quick Sequential Organ Failure Assessment (qSOFA) tool, 
and SIRS criteria to predict patients' inhouse mortality following admission through the 
ED. The researchers compared the qSOFA and the SIRs criteria to determine which can 
better predict admission to the ICU, a stay longer than 72 hours in the ICU, and/or sepsis 
related mortality from sepsis. The researchers concluded that the use of qSOFA resulted 
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in greater prognostic accuracy for in-hospital mortality than did either SIRS or severe 
sepsis to identify patients at high risk of mortality. This is a GRADE B study 
(Recommend, at least fair evidence). 
Oliver et al. (2018) conducted a retrospective chart review in a rural hospital in 
Arkansas with a 33-bed ED treating over 70,000 patients yearly. The researchers 
concluded that implementing a sepsis assessment tool can increase a sepsis patient's early 
recognition; decrease door-to-diagnosis times, presentation time to serum lactate 
measurement, and diagnosis to antibiotic times; and increase blood culture collection 
before antibiotic administration. This is GRADE B evidence (Recommend, at least fair 
evidence) 
Leisman et al. (2019) conducted a comparative study to (a) measure and compare 
the prevalence, characteristics, process, and patient outcomes of hospital-presenting 
sepsis (HPS) patients versus ED-presenting sepsis (EDPS) patients and (b) estimate risk 
differences in patient outcomes initial resuscitation disparities. The researchers used a 
retrospective analysis of the Northwell Sepsis Database of all severe sepsis and septic 
shock patients treated at a large hospital system in New York. The authors concluded that 
HPS patients had more complex presentations than the EDPS group, received timely 
antibiotics half as often as EDPS patients, and had twice the mortality odds. This is a 
GRADE E study as it is only a descriptive study and no recommendations were made 
(Evidence is insufficient to recommend for or against routinely; Evidence is lacking or of 
poor quality; Benefits and harms cannot be determined). 
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Level V Evidence 
Rhodes et al. (2017) used an expert panel to assess the quality of 2012 Surviving 
Sepsis Campaign guidelines. The expert panel researched and evaluated hemodynamics, 
infection, adjunctive therapies, metabolic, and ventilation. Questions on population, 
intervention, comparison, and outcomes (PICO) were reviewed and updated as needed. 
Each group developed clinical questions to search for and assess the quality of available 
evidence using the GRADE system. The expert panel developed a total of 93 statements 
on early management and resuscitation of patients with sepsis or septic shock with 32 
strong recommendations, 39 weak recommendations, and 18 best-practice 
statements. This is GRADE B evidence (Recommend, at least fair evidence). 
Nishida et al. (2018) also convened an expert panel in Japan to develop context-
specific CPGs for the care of sepsis patients. A total of 87 clinical questions were 
selected among 19 clinical areas, including pediatrics. A meta-analysis was conducted for 
29 of the clinical questions resulting in 37 recommendations in the form of an expert 
consensus due to insufficient evidence from the meta-analysis. No recommendations 
were provided for five clinical questions. This is GRADE E evidence (Evidence is 
insufficient to recommend for or against routinely; Evidence is lacking or of poor quality; 
Benefits and harms cannot be determined). 
Implications 
Sepsis is a medical emergency with a substantial mortality rate; however, many 
studies have shown that early identification and rapid resuscitative measures can improve 
patient outcomes and decrease the mortality rate (Dellinger et al. 2017; Oliver et al., 
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2018, Torsviket al., 2016). The 12 studies that I reviewed informed the development of 
the CPG for the project site. I categorized the studies based on their Level of Evidence 
(see Appendix B). Of the 12 studies, seven were done in an ED using screening tools, 
protocols, and clinical guidelines to improve the early recognition of sepsis. The authors 
of two studies (Nishida et al., 2016; Rhodes et al., 2017) used an expert panel to assess 
and improve the quality of previous guidelines, focusing on early management. Most of 
the researchers who used a screening tool or protocol found an improvement in reducing 
time-to-intravenous fluids and time-to-antibiotics in patients with suspected sepsis and 
improving recognition of sepsis. The implications for nursing practice include being able 
to identify sepsis in all patients; patients might not present with sepsis at triage but while 
awaiting a bed hence the inclusion of the three studies. The inclusion purpose is that 
nurses must identify sepsis in all patients, whether at triage or while awaiting inpatient 
beds. 
Recommendations 
Sepsis is a complex disease with a high mortality rate; therefore, the management 
of sepsis evidence-based guidelines are needed to decrease mortality adequately. Even 
though early sepsis intervention is critically important to patient survival, compliance in 
the clinical setting remains low. One primary issue is identifying sepsis early in a patient, 
as early recognition is crucial to sepsis outcomes. Sepsis treatment is time-sensitive 
research studies have recommended the early initiation of therapy for patient survival and 
quality of life. Furthermore, clinicians need to know the importance of time for sepsis 
patients and understand their roles in outcomes.  All clinicians must understand the 
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urgency and importance of time associated with sepsis management. Identifying sepsis in 
ED is a challenge as it can mimic other conditions; therefore, recommended protocolized 
management can assist clinicians in early identification and management. Recognizing 
these challenges, ongoing education, reinforcement of evidence-based guidelines can 
assist in early and optimal resuscitation. 
The institution’s problem relating to sepsis is the lack of early identification of 
patients presenting in the ED with sepsis-associated symptoms.  The initiation of a CPG 
on sepsis management may reduce ineffective practices, reduce morbidity and mortality, 
and improve the patient’s quality of life. The CPG is focused on three main areas: 
screening and recognition of sepsis, early assessment and management, and reevaluation 
of the patient during care. 
CMS sepsis guidelines recommend early sepsis care that includes early 
identification, and initiation of diagnostic testing and intervention. The proposed 
development of this guideline and its subsequent use can improve adherence to the SEP-1 
quality measures and improve early identification and management of sepsis in an urban 
ED with a documented need for improvement in these areas. The  purpose of this 
guideline is to 
 propose criteria for early recognition of the signs and symptoms of sepsis, 
severe sepsis, or septic shock 
 provide guidance in the timely implementation of evidence-based diagnostic 
interventions, treatment, and other therapies 
 reduce delays in initiating therapy and improve patient outcomes  
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 narrow the gap between the organization’s current practice and optimal 
evidence-based practice care 
 increase SEP-1 scores 
This CPG is focused on the adult patient, 18 years and older, presenting to the ED 
with confirmed or suspected sepsis or septic shock in a densely urban ED in a large 
Northeast city in the United States. I developed this CPG based on a critical analysis of 
the literature. The guideline is applicable to healthcare providers caring for adult sepsis 
patients in the ED. 
Definitions 
Sepsis: A clinical syndrome that triggers physiologic, biologic, and biochemical 
abnormalities. It is a multifaceted response to infection and results in organ dysfunction, 
which is attributed to insufficient tissue perfusion and oxygen delivery (Singer, 2016). 
Septic shock: A subset of sepsis in which particularly profound circulatory, 
cellular, and metabolic abnormalities substantially increase mortality (Seymour et al., 
2016). Septic shock is associated with hypotension and perfusion abnormalities despite 
the provision of adequate fluid (volume) resuscitation. Perfusion abnormalities include 
lactic acidosis, oliguria, or an acute alteration in mental status (Singer, 2016). 
Systemic inflammatory response syndrome (SIRS): A systemic response of the 
body to a harmful stressor such as infection, trauma, surgery, inflammation, ischemia, or 




The initiation of the following guidelines is expected to reduce delays in 
identifying and managing sepsis in the following areas: 
1. Early identification.  
2. Referral to appropriate provider. 
3. Rapid vascular access for laboratory testing and intravenous infusion. 
4. Empiric antibiotic therapy. 
5. Titrated fluid resuscitation. 
6. Early initiation of inotropes. 
1. Screening and Recognition of Sepsis in New Patients. All patients 18 years 
and older will be screened for sepsis by the triage nurse using the SIRS criteria. When 
two or more SIRs criteria are identified the nurse must initiate a SEPSIS CODE. The 
criteria for assessment are 
 temperature below 36 or above 38 degrees Celsius 
 systolic blood pressure (SBP) ≤ 90 mm Hg   
 heart rate greater than 90 breaths per minute  
 respiratory rate above 20 breaths per minute  
Rationale. Sepsis is a medical emergency in which outcomes depend on early 
recognition and rapid institution of resuscitative measures. Studies on early screening 
show that rapid intervention helps to decrease mortality in septic patients (Hayden et al., 
2016; Gatewood et al., 2015). Rhodes et al. (2016), Kim and Park (2019), and Morr, et al. 
(2016) stressed the importance of routine screening of potentially infected patients who 
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are likely to be septic to improve the early identification and treatment of sepsis. They 
highlighted the triage nurse’s role in the ED as crucial in the early recognition of sepsis 
symptoms because these nurses are usually the first contact for patients arriving in the 
department. 
Standard: 100%. The triage nurse will use the SIRS criteria for screening every 
patient over the age of 18 years who presents to the ED. 
2. Specific Assessment. All patients must have their vital signs taken, recorded, 
and evaluated by a Registered Nurse. The importance of temperature, heart rate, 
respiration and blood pressure monitoring are essential to identify patients with 
abnormality relating to sepsis. Ongoing evaluation of admitted patients can identify 
patients at risk for sepsis or septic shock.  
Rationale. Clinical evidence indicates that patients with acute deterioration or 
sepsis manifest clinical signs or symptoms several hours before the condition worsens 
(Roney et al, 2015).  Thus, early identification, rapid initiation of antibiotics, and 
adequate fluid resuscitation can lead to improvement in outcomes (Hayden, 2016).   
Standard: 100%. The triage nurse will use the document temperature, heart rate, 
respirations, and blood pressure for every patient over the age of 18 years who presents to 
the ED. 
3: Intervention. When a patient presents with two or more of the SIRS criteria, 
the nurse will commence the following immediate actions: 
 initiate a SEPSIS CODE 
 place the patient in an ED room or equivalent treatment area 
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 address any compromise in airway and breathing  
 attach cardiac and monitoring and oxygen saturation monitoring 
Within 10-15 minutes, the following actions need to be taken:  
 The medical provider must evaluate the patient. 
 The team must establish vascular access.  If necessary, use intraosseous 
needle (IO) for difficult vascular access. 
 Blood specimens must be obtained for include complete blood counts (CBC) 
with differential, chemistries, serum lactate levels, liver function tests, lactate 
levels, blood culture, blood gas, coagulation studies, type, and crossmatch 
(optional), and urinalysis. (At a minimum lactate, blood culture, CBC, 
Chemistries, urinalysis) 
 Initiate intravenous fluids resuscitation following the guidelines below. 
Within 3 hours, the nurse must repeat serum lactate levels. 
Rationale. The blood culture is the most important test in the management of 
sepsis, and the clinical significance of identifying the pathogenic microorganisms causing 
bacteremia. A blood culture should be taken prior to antimicrobial administration in 
patients with sepsis or septic shock.  The results will provide the source of infection 
necessary for the diagnosis of sepsis or septic shock.  The patient’s presenting signs and 
symptoms, medical history, physical examination, and laboratory results will determine 
the severity of the sepsis.   
Standard: 100%. The triage nurse and medical provider will adhere to all 
immediate, 15 minute, and 3-hour criteria.   
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4. Empiric Antibiotic Therapy. Administer broad-spectrum antibiotics within 
one hour of identification after obtaining blood cultures. 
Rationale. Identification of the site of infection is vital to target antibiotic therapy. 
The five possible sites causing sepsis are: 1) intra-abdominal infection, 2) infectious 
pancreatic necrosis, 3) vascular catheter-associated infection, 4) urethral sources, and 5) 
necrotizing soft tissue infection. Empiric antibiotics should be selected based on the 
patient’s background, organs suspected to be affected, epidemiological information, and 
recent use of antibiotics. The patient’s allergy history must be obtained before antibiotic 
administration.  According to the results of several studies, hourly delays in antibiotic 
administration can increase the odds of hospital mortality (Lui et al., 2017; Corl et al., 
2020, Singer, 2017, Whiles, Deis, & Simpson, 2017). The recommendation is to 
administer broad-spectrum antibiotics within one hour of identification and after 
obtaining blood cultures. 
Standard: 100%. Broad-spectrum antibiotics will be administered within one 
hour of identification and after obtaining blood cultures. 
5: Titrated Fluid Resuscitation. Initiating an access line is important in 
obtaining labs, providing medications, and replacing loss fluid in patients with sepsis or 
sepsis shock.  The initial fluid administration is a bolus of 30 ml/kg crystalloid for 
hypotension or a serum lactate of > 4 mmol/L within an hour of suspected sepsis or septic 
shock.  Crystalloids are the recommended fluid of choice for initial resuscitation and 
subsequent intravascular volume replacement. 
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Rationale. Sepsis is associated with vasodilation, capillary leakage, and decreased 
circulating blood volume.  This can lead to impaired tissue perfusion and organ 
disfunction. The goal of fluid resuscitation in sepsis and septic shock is to restore 
intravascular volume, increase oxygen delivery, and reverse organ dysfunction.  
Resuscitation with initial fluid bolus requires evaluating the benefits and risks of fluid 
administration based on the patient’s assessed volume status.  For example, a patient with 
heart failure may be considered fluid overload and the administration of fluids may 
worsen this condition.  However, the heart failure patient can die from sepsis if not 
adequately treated whereas the fluid overload can be reversed. 
Standard: 100%. An initial fluid administration bolus of 30 ml/kg crystalloid for 
hypotension or a lactate of > 4 mmol/L within an hour of suspected sepsis or septic 
shock.   
6: Early Initiation of Inotropes. Placement of an arterial catheter as soon as 
practical is recommended for patients requiring vasopressors  
Rationale. Vasopressors and inotropes restore oxygen delivery to tissues by 
increasing mean arterial pressure (MAP) and cardiac output.  The practitioner must 
consider the administration of vasopressors for hypotension that does not respond to fluid 
bolus to maintain a MAP of 65 mm/Hg or greater.  The drugs of choice include 
Norepinephrine as the first choice for vasopressor, but indicated only in selected patients 
(e.g., patients with low risk of tachyarrhythmias and absolute or relative Bradycardia). 
Vasopressin (up to 0.03U/min) or Epinephrine to raise the MAP to target is suggested.  
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Adding Vasopressin (up to 0.03U/min) to decrease Norepinephrine dosage and 
Dopamine as an alternative vasopressor agent to Norepinephrine. 
Standard: 100%. The medical provider must consider the administration of 
vasopressors for hypotension that does not respond to fluid bolus to maintain a MAP of 
65 mm/Hg or greater. 
Expert Panel Review of the Clinical Practice Guideline 
An expert panel was convened to assess the CPG using the criteria in the AGREE 
II tool.  The panel consisted of an ED medical director, an ED Director of Nursing, an ED 
nurse manager, and an ED staff nurse. The AGREE II  tool includes criteria to assess the 
quality of a guideline's development process by six domains which include: scope and 
purpose, stakeholder involvement, the rigor of development, clarity, and presentation, 
application, editorial independence; Each domain of the Agree II tool includes items 
numbered from 1 to 7, with each domain having a score calculated; an overall score is 
then calculated by summing all the domains (see Table 3). Also, each evaluator selected 
one of two overall guideline assessment choices: "lowest possible quality” or “highest 







AGREE II Tool Domains   Description 
1. Scope and purpose  
 
Project question and CPG aligns with the 
Picker domains of patient centered care.  
 
2. Stakeholder involvement  
 
 
Four expert panelists involved in review.  
 
3. Rigor of development  
 
 
Best practices, current guidelines and evidence 
used in development.  
 
4. Clarity of presentation  
 
 
CPG, and resources were clear and supported 
with evidence.  
 
5. Applicability  
 
 
CPG and resources can be applied in a variety 
of settings.  
 
6. Editorial Independence  
 
 
Each panelist completed an individual review 
and presented individual comments.  
 
I performed an analysis of the AGREE tool answers and scores completed by the 
four evaluators according to the six domains of the AGREE II tool (see Table 4). The 
Sepsis Clinical Guidelines scored highest in the domain of the guideline's scope and 
purpose and clarity and presentation. All four evaluators gave the highest score for the 
specific recommendations with clarity and the key recommendations as easily 
identifiable. The stakeholder involvement and domain and editorial were having the 
lowest scores. The evaluators gave high scores on the overall guideline assessment and 
100% recommended the guideline for use (see Table 5). Three recommended without 
modification; one evaluator scored recommended the guideline with modifications for 
use in the ED, however, the modifications were not specified. All evaluators scored 
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inclusion of patient stakeholders at the lowest level; however, this was to be expected as 
this project was guided by the Rosswurm and Larrabee model of evidence-based practice 
development Stages 1 through 4. In this model, stakeholders are part of the 









Scope and purpose 
 
1. The overall objective(s) of the guideline is (are) specifically described. 21/21 
100% 
2. The health question(s) covered by the guideline is (are) specifically described.  









5. The views and preferences of the target population (patients, public, etc.) have been 
sought. 
 
6. The target users of the guideline are clearly defined.  
Rigor of development 7. Systematic methods were used to search for evidence. 50.25/56 
90% 
8. The criteria for selecting the evidence are clearly described.  
9. The strengths and limitations of the body of evidence are clearly described.  
10. The methods for formulating the recommendations are clearly described.  
11. The health benefits, side effects and risks have been considered in formulating the 
recommendations. 
 
12. There is an explicit link between the recommendations and the supporting evidence.  
13. The guideline has been externally reviewed by experts prior to its publication.  
14. A procedure for updating the guideline is provided.  
Clarity of presentation 15. The recommendations are specific and unambiguous. 20/21 
95% 
16. The different options for management of the condition or health issue are clearly 
presented. 
 
17. Key recommendations are easily identifiable.  
Applicability 18. The guideline describes facilitators and barriers to its application. 23/28 
82% 
 
19. The guideline provides advice and/or tools on how the recommendations can be put into 
practice. 
 
20. The potential resource implications of applying the recommendations have been 
considered. 
 
21. The guideline presents monitoring and/ or auditing criteria.  
Editorial independence 22. The views of the funding body have not influenced the content of the guideline. 8/14 
57% 











1. Rate the overall quality of this guideline. 





 Panel Rating       4 
     
Overall Guideline 
Assessment 
2. I would recommend this guideline for use. Yes Yes, with modifications No 
3 1 0 
 
Contribution of the Doctoral Project Team 
The team consisted of an ED medical director, ED director of nursing, ED nurse 
manager, and ED staff nurse. This expert panel assessed the CPG using the AGREE tool 
criteria. The guideline was recommended for use by the expert panel for nurses to review 
either on their smart phones or internet-based learning-based management system 
available in the ED (Healthstream). 
Strengths and Limitations of the Project 
There are strengths and limitations to this DNP doctoral project. This project's 
main strength is its significance to the intended target audience, which are patients 
presenting to the ED with suspected sepsis and registered nurses who need to identify 
these patients so that early treatment can begin. The registered nurses' have a pivotal role 
in identifying septic patients; having resources for guidance will reinforce the nurses' 
knowledge and use of the evidence-based sepsis CPG to improve patient outcomes. 
Using evidence-based sepsis guidelines within the project institution will be integrated 
into the merging hospitals to provide care in a widening area and throughout the 
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organizations. The project is limited by its inability to include patient stakeholders in the 
process of development.  
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Section 5: Dissemination Plan 
This project was the development of a CPG for use in the ED with input from an 
expert advisory panel using the AGREE II criteria. The clinical guideline offers a sepsis 
screening for clinicians in the ED in identify sepsis early to improve early targeted 
treatment, thus improving sepsis patient outcomes for patients in the surrounding 
community. The goal is to improve the early identification of sepsis symptoms and 
prompt interventions to optimize sepsis care and improve the quality of life of individuals 
in the community receiving sepsis care from the ED. Adequate evidence-based 
intervention is crucial to patients’ survival; therefore, all clinicians providing care to the 
institution patients need to be educated and aware of the morbidity and mortality of sepsis 
and their role in improving the outcomes for these patients. 
Dissemination of evidence-based practices can provide needed resources to assist 
clinicians in providing the sepsis management care that is needed. Dissemination is a 
vital factor of the quality improvement cycle by integrating the best available evidence 
into standard practice. Dissemination of the project interventions of improving early 
identification of sepsis symptoms of patients arriving in the ED can improve nursing 
practices. I plan to share the quality improvement intervention with the project site’s ED. 
This may encourage improvement in the EPIC triage prompts.  
Analysis of Self 
The lesson I learned in conducting this project is that organizational leadership 
must be knowledgeable about evidence-based guidelines. I also learned that the 
responsibility of an effective project leader involves conducting proper research when 
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proposing change. This is done by using current evidence-based knowledge to guide 
practice strategies and highlight quality improvement based on proven evidence. As I 
learned, implementing a quality improvement strategy or project necessitates bridging the 
gap between current practice and evidence-based practice by identifying the barriers and 
facilitators of change. Clinical experience with the various nursing leaders empowers me 
to develop evidence-based quality improvement projects/interventions within the 
constraints of time and the institution's resources. This lesson learned from this project is 
the meaning and importance of interprofessional collaboration, particularly about use of a 
CPG for early recognition of sepsis in the ED, which will ultimately improve nursing 
practice and patient outcomes. 
Summary 
In this project, I developed a CPG, informed by Rosswurm and Larrabee’s 
evidence-based practice model and a literature search for use in the ED with input from 
an expert advisory panel using the AGREE II criteria. Panel members unanimously 
recommended the use of the guideline.  In making sepsis screening a routine practice 
informed by a clinical guideline, nurses can maximize outcomes of this population and 
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Appendix A: Sepsis Bundles 
I created this table based on information in Rhodes et al. (2017). 
3-hour and 6-hour sepsis bundle 2018 upgraded 1-hour bundle 
3-hour bundle 
Measure serum lactate. 
 
Obtain blood cultures prior to antibiotic 
administration. 
 
Administer broad-spectrum antibiotics 
within 3 hours from time of 
presentation. 
 
Administer 30ml/kg crystalloid for 
hypotension or lactate ≥ 4mmol/L. 
 
6-hour bundle 
Apply vasopressors for hypotension not 
responding to initial fluid resuscitation 
to maintain mean arterial pressure 
(MAP) ≥ 65mm Hg. 
 
In the event of persistent hypotension 
despite fluid resuscitation and/or lactate 
> 4mmol/L. 
 
Measure central venous pressure 
(CVP). 
 
Measure central venous oxygen 
saturation (ScvO2) of ≥70%. 
 
Remeasure lactate if initial lactate was 
elevated. 
Measure lactate level. Re-measure if 
initial lactate is > 2mmol/L (weak 
recommendation, low quality of 
evidence). 
 
Obtain blood cultures prior to 




antibiotics (strong recommendation, 
moderate quality of evidence). 
 
Rapidly administer 30ml/kg 
crystalloid for hypotension or lactate 
≥ 4mmol/L (strong recommendation, 
low quality of evidence). 
 
Apply vasopressors if patient is 
hypotensive during or after fluid 
resuscitation to maintain MAP ≥ 
65mm Hg (strong recommendation, 





Appendix B: Table of Evidence 




Method Findings that answer the question Limitations Level of evidence 
 








Pre- and post-intervention 
study in one emergency and 
community hospital within 
the Mid-Norway Sepsis Study 
catchment area. All patients 
with confirmed bloodstream 
infection were 
registered on a  
continuous 
basis from 1994. 
This research reported that early sepsis 
recognition by ward nurses might have 
reduced the progression of disease and 
improved survival for patients in hospital 
with sepsis. 
One of the study’s has 
important limitations such 
as the use of a historical 
pre-intervention group, 
which does not ensure 
comparison between pre-& 
post 
intervention and post-
intervention groups. . 
 
III 












was 9%. Of the 
39 patients who 
screened 
positive, 51% 
were positive for 
sepsis, and 49% 
screened positive 






The researchers demonstrated that a 
simple screening tool for sepsis utilized 
as part of nursing assessment may be a 
useful to identify early sepsis in both 
medical and surgical patients in an 









 Limitations are  that the 
study was conducted in 
one unit. 
III 





672  patients  Retrospective analysis was 
performed at a specialist 
oncology hospital in the 
Northwest of England 
During the study period, 697 patients 
with suspected sepsis post chemotherapy 
were included in the study. Six hundred 
seventy-two (96.4 %) patients received 
their first dose of intravenous antibiotics 
within 60 min of presentation to the 
institution. Of this group, 323 (48.1 %) 
were administered antibiotics within 15 
min of arrival. Of the 25 (3.6 %) patients 
who did not receive antibiotics within 1 
h, root cause analysis revealed the reason 
in 23 (92 %) patients was an inability to 
ascertain intravenous access. 
The study is limited 
because it was performed 
in a specialist tertiary 










Method Findings that answer the question Limitations Level of evidence 
 
Nurse-led protocols can be used as an 
effective, safe method in achieving early 
 intervention with antibiotic 
for patients with suspected febrile 
neutropenia. (sepsis) 










The study established a statistically 
significant 230-minute reduction in time 
to antibiotics post implementation of the 
guidelines.  
The sepsis guidelines improved early 
assessment, recognition and management 
of patients presenting with sepsis in one 
tertiary referral emergency department. 
The study was conducted 
in one urban Australian 
tertiary referral ED, and 
the results may not 
represent other EDs or 




Rhodes et al. (2016) Expert Opinion Assess the 
quality of 2012 
SSC guidelines 
The panel were group 




metabolic, and ventilation. 
Population, intervention, 
comparison, and outcomes 
(PICO) questions were 
reviewed and updated as 
needed, and the generation of 
evidence profiles 
The Surviving Sepsis Guideline panel 
provided 93 statements on early 
management and resuscitation of patients 
with sepsis or septic shock. Overall, 32 
were strong recommendations, 39 were 
weak recommendations, and 18 were 
best-practice statements. No 
recommendation was provided for four 
questions. 
One in person meeting 
other by teleconference.  
V 
Nishida et al. 
(2018) 
Expert Opinion Adult patients 
with confirmed 
or suspected 
sepsis or septic 
shock.  
Meta-analyses for 29  
clinical sepsis questions 
and three large scales RCTs  
The committee developed clinical 
practice guidelines for the Japanese 
healthcare clinicians  
None noted V 






on EGDT to 
reduce mortality 
with in severe 
sepsis and septic 
shock.  
Data from all 
trials were 
combined and 
analyzed using a 
random effects 
model. 
Relevant primary studies 
were identified by searching 
the MEDLINE and EMBASE 
databases and the Cochrane 
Central Register of Controlled 
Clinical Trials to identify 
randomized controlled trials 
assessing the effectiveness of 
EGDT for sepsis. 
The study did not permit a definitive 
conclusion of the utility of EGDT in 
severe sepsis and septic shock due to. 
variation in study  
outcomes. 
None noted I 








analyzed in the 
study 
Retrospective data 
comparison between the pre- 
and post-intervention group 
The investigators concluded that the use 
of an EHR-based triage sepsis alert and 
SWAT protocol led to a major reduction 
Fewer charts were 










Method Findings that answer the question Limitations Level of evidence 
 
with 108 charts 
in the pre-SWAT 
group, and 130 





in the time to intravenous fluids and time 
to antibiotics  







in a rural ED  
 
Analysis of a chart review 
using a pre- and post-
screening tool 
The use of a screening tool led to a 
decrease in door to antibiotic time 
There were two 
limitations.  
a) the study was conducted 
in a single ED. 
 b) the study was 
conducted over a short 
time of three.  
months 
IV 







Done in nine 
hospitals over 
two years. 












Analysis of the hospital 
Sepsis Database, a 
prospectively, of a 
consecutive-sample cohort of 
all “severe sepsis” and septic 
shock patients treated at nine 
tertiary and community 
hospitals  
The investigators found that hospital-
presenting sepsis (HPS) patients had 
higher comorbidity and clinical 
presentations and had more significant 
mortality, LOS, and ICU utilization than 
emergency department-presenting sepsis 
(EDPS).  
The EDPS patients received antibiotics 
and fluids 1.62- 82 times more often than 
HPS patients.   
The study did not 
differentiate between HPS 
patients admitted for 
noninfectious reasons and 
who became septic versus 
non-septic patients 
admitted for an infection 
who then became septic 
from that infection. 
IV 






ED patients 18 
years and older 
with suspected 
infection, and 
two or more 
systemic 
response 
Pre and post interventional 
screening tool analysis 
The analysis showed a decreased in door 
to antibiotic timing.  
The study data did not conclude there 
was a decreased in door to diagnosis, 
door to lactate measurement or increased 
in blood culture obtained before 
antibiotic administration. 
The study was conducted 
in one hospital, and had a 
short time applying 
 the screening tools. 
IV 






185 patients with 
severe sepsis or 
septic shock in 
the pre-triage 
tool group and 
To determine the effect of a 
triage screening tool on time 
to antibiotics in patients with 
severe sepsis or septic shock 
presenting to the ED. 
The implementing of the triage 
assessment tool result in decreased time 
to antibiotics by 21%. Sixty-four percent 
of the patients who qualified for the 








Method Findings that answer the question Limitations Level of evidence 
 
170 patients in 
the post-triage 
tool group 
study were appropriately identified and 
triaged post implementation 
Although there was moderate adherence 
(64%), the implementing of a sepsis 
screening tool at triage have decreased 
the time from triage to antibiotic 
administration in patients presenting with 
suspected severe sepsis or septic shock 
 
